NYU develops new drug that attacks cancer cells without harming healthy ones by a new protein-engineering technique to develop antibodies that recognize only mutant HER2 | The researchers say the new technique may lead to new ways to treat patients with some cancers with minimal side effects.
Read Full Article
#NYU #CancerResearch #ProteinEngineering #HER2Antibodies #HealthcareInnovation
Read Full Article
#NYU #CancerResearch #ProteinEngineering #HER2Antibodies #HealthcareInnovation
Nature
Selective targeting of oncogenic hotspot mutations of the HER2 extracellular domain
Nature Chemical Biology - Using directed evolution and structure-guided design, human synthetic antibodies selective to HER2 point mutants were developed. The use of the antibodies as T cell...
👏3
Scientists glue two proteins together, driving cancer cells to self-destruct
Read Full Article
#CancerResearch #ProteinEngineering #CellBiology #MedicalInnovation #HealthScience
Read Full Article
#CancerResearch #ProteinEngineering #CellBiology #MedicalInnovation #HealthScience
News Center
Scientists glue two proteins together, driving cancer cells to self-destruct
Stanford researchers hope new technique will flip lymphoma protein's normal action - from preventing cell death to triggering it.
🔥4👍1
AI model simulates 500 million years of evolution to generate a novel protein
Read Full Article
#AIEvolution #ProteinEngineering #Biotechnology #Innovation #SyntheticBiology
Read Full Article
#AIEvolution #ProteinEngineering #Biotechnology #Innovation #SyntheticBiology
Earth.com
AI creates new protein that simulates 500 million years of evolution - Earth.com
Scientists used AI to design a fluorescent protein unlike any seen before. The AI model, ESM3, simulates evolution on a massive scale.
🔥4